A drug company has reversed its decision to deny giving a critically ill 7-year-old cancer patient a life-saving anti-viral medicine. The company, Chimerix, said it had reached an agreement with the Food and Drug Administration to make the drug, Brincidofovir, available to the boy, Josh Hardy, from Fredicksburg, Va., Fox News
Hardy's family had launched a social media campaign to appeal to the company to provide the experimental medication for Josh to treat an adenovirus attacking the boy after cancer treatments.
Family and supporters of the boy were ecstatic Wednesday, after a drug company reversed its decision to deny him the medicine.
"We’re just looking forward to the great success of the drug and the great success of the company to help other people, just tremendously excited," said Josh's mother, Aimee, on Fox & Friends Wednesday. "As hard as we were as a group on the company, we’re going to push Josh to continue to do his best so that he can make that full recovery."
She said Josh had been cancer-free for two years. In January, he underwent chemotherapy and a bone marrow transplant at St. Jude Children's Research Hospital in Memphis, Tenn., but he later developed adenovirus — an acute infection that can be deadly in people with compromised immune systems.
She said doctors at St. Jude recommended Josh be treated with Brincidofovir, but the drug has not yet been approved by FDA, so Josh hasn't been able to gain access to the medication.
Chimerix, the company that manufactures Brincidofovir, initially refused to provide the drug, citing the lac, of FDA approval, but reversed that decision late Tuesday.